Physician profile
Mark Allison
NPI 1891795480
$2,670.91
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $300 · 2021: $324 · 2022: $481 · 2023: $579 · 2024: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,295.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $844.17 | 2022-2024 | Lumigan, Alphagan P, Vuity |
| Allergan, INC. | $541.53 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $400.24 | 2019-2024 | Cequa, Xelpros |
| Novartis Pharmaceuticals Corporation | $280.07 | 2019-2023 | |
| Biotissue Holdings INC. | $142.60 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $92.99 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $63.56 | 2024 | Xdemvy |
| Horizon Therapeutics Plc | $52.45 | 2023 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $43.13 | 2019-2021 | |
| Amgen INC. | $38.79 | 2024 | Tepezza |
| Shire North American Group INC | $37.64 | 2019 | |
| Kala Pharmaceuticals, INC. | $31.18 | 2021-2022 | |
| The Cameron-Ehlen Group, INC. | $26.97 | 2019 | |
| Bausch & Lomb Americas INC. | $21.81 | 2024 | Miebo, Vyzulta |
| Thea Pharma INC. | $20.36 | 2023 | Iyuzeh |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $17.13 | 2024 | Vevye |
| Rxsight INC | $16.29 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Allison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.